BRISTOL-MYERS SQUIBB COMPANY

Official Publications Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Market Closed - Nyse Other stock markets 04:00:01 2024-05-20 pm EDT			Pre-market 08:26:11 am
43.36 ^USD	-1.48%		43.66	+0.68%

02:34pm	Bristol-Myers Squibb Says US FDA Reassigns Action Date Subcutaneous Nivolumab	MT
01:32pm	Bristol Myers: deadline set for subcutaneous Opdivo	CF

Official Publications

Slide show Q1	23-04-26	CO
1st quarter results	23-04-26	CO
Annual Report	23-04-26	CO
SEC Filing 8K	23-04-26	CO
SEC Filing 8K	23-04-25	CO
Proxy Statments	23-03-22	CO
SEC Filing 10K	23-02-13	CO
Slide show results	23-02-01	CO
Annual results	23-02-01	CO
SEC Filing 8K	23-02-01	CO
SEC Filing 8K	23-01-30	CO
SEC Filing 8K	23-01-08	CO
Slide show Q3	22-10-25	CO
3rd quarter results	22-10-25	CO
SEC Filing 10Q-2	22-10-25	CO
SEC Filing 8K	22-10-25	CO
SEC Filing 8K	22-07-26	CO
SEC Filing 10Q-2	22-07-26	CO
1st-half-year results	22-07-26	CO
Slide show half-year results	22-07-26	CO
SEC Filing 4K	22-06-15	CO
SEC Filing 8K	22-06-14	CO
Dividends	22-06-14	CO
Slide show Q1	22-04-28	CO
1st quarter results	22-04-28	CO

1 2 3

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Headlines

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 01:06 pm EST

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW